Healthcare -
Biotechnology - NASDAQ - US
$ 2.08
8.9 %
$ 75.1 M
Market Cap
-0.47
P/E
Price Target
Average
765.38%
Revenue Forecast
Estimate
451.02%
EBIT
Estimate
1.11%
Net Income
Estimate
51.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Inovio Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for INO of $18 , with forecasts ranging from
a
low of
$4 to a high of $40 .
INO Lowest Price Target
Wall Street Target
4 USD
92.31%
INO Average Price Target
Wall Street Target
18 USD
765.38%
INO Highest Price Target
Wall Street Target
40 USD
1823.08%
REVENUE FORECAST
Revenue Forecast Chart INO
EBIT FORECAST
EBIT Forecast Chart INO
NET INCOME FORECAST
Net Income Chart INO